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86A ABSTRACI'S 
NO-RELEASING MOLSIDOMINE AUGMEN!PS ASPIRIN - 
INDUCED PLATELET INHIBITION 
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The antiangial sydnonimine derivative 
molsidomine 0401) acts as a vasodilator and 
inhibitor of platelet aggregation via its 
hepatic metabolite SIN-I releasing nitric 
oxide (NO). In this study 5 groups of 8 
volunteers each, pretreated with aspirin 10, 
30, 100 or 500 mg or placebo for 7 days, were 
tested for platelet antiaggregatory effects of 
Mol ( 8mg 1 orally administered. Serum 
TXBa-formation and collagen-inducon 
aggregation in platetet-rich plasma were 
dose-dependently reduced by aspirin. After Mol 
aggregation in response collagen was 
significantly delayed. r:: whole blood 
platelet-activating factor (lOvg/ml) -induced 
platelet aggregation measured by the impedance 
method and ATP release were significantly 
reduced after pretreatment with aspirin 100 
and 500 mg and were further diminished 
following oral Mol. 
Thus, aspirin (100 and 500 mg/d) -induced 
reduction in platelet aggregation is 
significantly enhanced by the antianginal 
agent molsidomine. 
PROSTACYCLIN ANALOG MAINTAINS BLOOD FLOW DESPITE INTRA- 
CORONARY THROMBUS FORMATION IN A CANINE MODEL. 
JudilbK. Megan Cronin, B.S., Karl Lee, B.S., 
Soott Almy, Benedict R. Lucchesi, Ph.D., M.D., U of MI, Ann Arbor, MI 
Prostacyclin analogs prevent platelet regation in wilro. Platelet activation 
contributes 10 coronary artery thrombosis. We compared in wiku and in viwo 
effect of ilopros! (ILO) in preventing platelet aggregation and thrombosis in a 
model of lntimal left circumflex coronary artery (LCCA) injury induced by 100 
pA DC. Anesthetized dogs were randomized to IL0 100 ngIkg!min intra atrial 
(n-11) or saline (CT, n-11). initial hemodynamlc variables did not differ be- 
tween groups. The first 2 hours mean arterial pressure (MAP) fell during IL0 
lnfusbn bul heart rate did not change. LCCA blood fbw was stable for 5h 
with IL0 (29k2 to 22k8 mllmin) but fell in CT (28 k4 to 8i4 mumin, psO.05). 
The time to thrombosis was similar [ILO 12&42 min (n=4), CT 93k28 min 
(n-7)], as was the incidence of thrombosis. Thrornbus mass was similar (IL0 
7.3&l .6 mg, CT 11.8k2.2 mg), as were 1 1 1 in&urn-labeled plateletslmg of 
thmmbus (IL0 52&131 wmhna, CT 597M9 wm/mol. Platelet dewsi!iQn 
at the site bf Injury de!ert&ed 6y comparative r&s V%S higher in t’hc mi& 
LCCA of CT dogs: IL0 2.7kg.4 va CT 5.1&l .l , p~O.05. Platelet counts in- 
creased over time but were not diiereti between groups. Ex viva platelet ag- 
gregation induced with two concentrations of arachiinic acid, collagen, and 
ADP were similar in the IL0 and CT groups. In vitro platelet aggregation in- 
duced wlh high concentration 01 agonists was lnhlbited with 100 nM, 33 nM 
and 10 nM IL0 (~~0.05). The in v&o area of left ventricle perfused by the 
LCCA was similar (IL0 32&l%. CT 31&.2%1. IL0 stabilized LCCA blood flow 
al baseline levels despite a 28%fali in MAP’& it did not prevent some acute 
LCCA thrombotic occlusions or significantly limti developing thrombus. Plate- 
let accumulation in thrombi was not prevented nor was 8x vhro platelet aggre- 
gation inhibited, but deposition on injjred vascular endothelium was limited. 
The extent to whii IL0 rnain!ained LCCA blood flow may be related to i!s va- 
sodilating properties and prevenlion of platelet adheslon to vascular endo- 
theliim. 
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The effects of U-61.431F (U), methyl-carbaprostaglandin 
12, a stable prostacyclin analogue, were examined on the 
proliferaticn of cultured bovine aortic endothelial cells 
(EC) and smooth muscle cells (WC). Quiescent EC and SMC 
were stimulated with 5% fetgl calf serum for 24 hrs. DNA 
synthesis was assessed by [ Hlthymidine incorporation 
into DNA in each cell. 
Values are mean X of vehicle-treated control cultures. U, 
3-loo@!, suppressed DNA synthesis in WC in a dose- 
dependent manner. However, U did not affect DNA synthesis 
in EC up to 3OttM. At every concentration, more 
suppression of DNA synthesis was observed in SMC than in 
EC. Quiescent SMC were also stimulated with lOng/ml PDCF 
for 2 hrs followed by the stimulation with lOOng/ml 
insulin for 22 hrs. U, (10~OJIM), did not inhibit DNA 
synthesis significantly when added at the time of PDW 
stimulation. Thus, U inhibits SMC proliferation acting in 
the pro ression stage rather than in the competence 
sta e. 
a 
!! ince inhibition of SMC proliferation by U occurs 
wit little inhibitory effect on EC, U seems to be useful 
in the prevention of abnormal growth of SMC after 
vascular injury. 
COHPABATIWE EFFICACY OF 
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The non-selective inhibition of lplatelet and vessel 
wall cycloomgenase by aspirin, witi the potential for 
inhibition & PGI2 &nthesis -and therefore Qecreased 
efficacy. has led- to the search for aaore aelective 
antithrbahbotic @Bents. Treatment with the thromboxane 
synthetase inhibctor. CW 4151. has been associated with 
a- decrease in se&n TxA2 end an increase in 
PGI2 levels. Accordinsly,- the antithrombotic efficacy 
of - cv 4151 
- - 
and aspirin was compared in 
non-anticoaSulateQ pigs uGdergoing bilaterel carotid 
arterial injury by balloon engioplasty (5 inflations to 
6 atm for 30 set each, 60 sic -apart), and sacrificed 
within one hour of the procedure. Aspirin (1 
day), CW 4151 (100 bid) or placebo bid were 
tug/kg per 
started 2 
days prior to the sxperiment. Quantitative Indium-111 
labelled platelet deposition and mural throubus 
formation at the site of deep arterial wall injury are 
shown below (x f SEM>: 
UO. 
arteries 
Platelet deposition arteries with 
mural thrombus 
Placebo 
Cu 4151 
Aspirin 
* p vs placebo ~0.025; + p vs placebo <O.Ol 
Thus, at the dose tested, both aspirin and CW 4151 are 
equally effective antithrkbotic aients. with no clear 
superior benefit of Cv 4151 in this iodel. 
